These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9915227)

  • 1. Microalbuminuria in diabetes.
    Mangili R
    Clin Chem Lab Med; 1998 Dec; 36(12):941-6. PubMed ID: 9915227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
    Forsblom CM; Groop PH; Ekstrand A; Groop LC
    BMJ; 1992 Oct; 305(6861):1051-3. PubMed ID: 1467683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
    Chiarelli F; Verrotti A; Mohn A; Morgese G
    Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to protect the kidney in diabetic patients: with special reference to IDDM.
    Mogensen CE
    Diabetes; 1997 Sep; 46 Suppl 2():S104-11. PubMed ID: 9285510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary prevention of diabetic nephropathy].
    Trevisan R
    G Ital Nefrol; 2012; 29 Suppl 58():S49-53. PubMed ID: 23229603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetic nephropathy. Microalbuminuria and perspectives for intervention in insulin-dependent diabetes.
    Mathiesen ER
    Dan Med Bull; 1993 Jun; 40(3):273-85. PubMed ID: 8339600
    [No Abstract]   [Full Text] [Related]  

  • 13. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How I evaluate...diabetic nephropathy. First part: micro- and macroalbuminuria].
    Weekers L; Scheen AJ; Lefebvre PJ
    Rev Med Liege; 1998 Aug; 53(8):494-8. PubMed ID: 9810212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.
    Parving HH; Hommel E; Mathiesen E; Skøtt P; Edsberg B; Bahnsen M; Lauritzen M; Hougaard P; Lauritzen E
    Br Med J (Clin Res Ed); 1988 Jan; 296(6616):156-60. PubMed ID: 3122980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of microalbuminuria in type 1 diabetes.
    Perkins BA; Ficociello LH; Silva KH; Finkelstein DM; Warram JH; Krolewski AS
    N Engl J Med; 2003 Jun; 348(23):2285-93. PubMed ID: 12788992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing diabetic nephropathy: an audit.
    Hansen HP; Lund SS; Rossing P; Tarnow L; Nielsen FS; Jensen T; Parving HH
    Scand J Clin Lab Invest; 2001; 61(6):471-7. PubMed ID: 11681537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.